Catalyst Pharmaceuticals, Inc.

NEW YORK LIFE INVESTMENT MANAGEMENT LLC CPRX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/10/2026

Shares

88,339

Value ($000)

2,776

Weight

0.0%

2022 Q2 - 2026 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/10/2026	2,776	0.0%	88,339	6/30/2026
2024 Q1	5/6/2024	361	0.0%	22,640	3/31/2024
2022 Q4	2/10/2023	1,273	0.0%	68,427	12/31/2022
2022 Q3	11/10/2022	784	0.0%	61,087	9/30/2022
2022 Q2	8/12/2022	394	0.0%	56,253	6/30/2022